by | Oct 26, 2010 | Towing
DuPont (DD) reported third-quarter earnings of 40 cents per share, down from 45 cents per share a year earlier.
Sales grew 17% from a year earlier to $7 billion, the company said in a statement. Sales grew 22% in emerging markets.
Sponsored Links
The company saw a decline of 13 cents per share in pharmaceuticals income related to patent expirations.
“I am proud of our business teams’ performance…
Continue reading DuPont Earnings Drop, but Raises Outlook
DuPont Earnings Drop, but Raises Outlook originally appeared on DailyFinance on Tue, 26 Oct 2010 06:40:00.
Filed Under: Company News, Health Care, Earnings, Retail, DuPont
by | Oct 25, 2010 | Towing
Tiny, little-known biotech Clinical Data has developed a potential blockbuster drug called Vilazodone. If OK’d, it would be the first new depression treatment in 15 years. Its potential is so huge that several Big Pharmas are s…
by | Oct 20, 2010 | Towing
Shares of pharmaceutical companies Amylin, Alkermes, and Eli Lilly — partners in a new diabetes drug Bydureon — have tanked in morning trading as the U.S. Food and Drug Administration declined on Tuesday to approve the drug w…
by | Oct 18, 2010 | Towing
At a recent life-sciences conference in Stockholm, execs of several U.S. and foreign biotechs clashed with Big Pharma in a lively debate on the merits of their respective goals and products. The result, however, was a stand-off…
by | Oct 8, 2010 | Towing
Sanofi-Aventis (SNY) said Friday it plans to lay off 1,700 workers at its U.S. pharmaceutical operations, which amounts to about 25% of its U.S. workforce. The cutbacks are part of an ongoing restructuring to streamline its business amid a “challenging…
